Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Oaktree Nears Deal for Majority Stake in 2 B. Riley Units, Bloomberg Reports
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Oaktree Nears Deal for Majority Stake in 2 B. Riley Units, Bloomberg Reports
Aug 21, 2024 10:10 PM
11:57 AM EDT, 08/21/2024 (MT Newswires) --
Price: 5.75, Change: +0.27, Percent Change: +4.83
Previous page:
Why Revelation Biosciences (REVB) Stock Is Down 38%
Next page:
Honeywell International's Deal With Bombardier Neutral-to-Slightly-Positive, RBC Says
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Why Revelation Biosciences (REVB) Stock Is Down 38%
Dec 3, 2024
Revelation Biosciences Inc ( REVB ) shares are trading lower by 38% to 58 cents during Tuesday’s session after the company said it entered a definitive agreement for the immediate exercise of outstanding warrants to purchase 4,064,040 shares of common stock at $1.00 per share. The shares, registered under a Form S-3 filing, are expected to generate approximately $4 million...
Honeywell International's Deal With Bombardier Neutral-to-Slightly-Positive, RBC Says
Dec 3, 2024
10:58 AM EST, 12/03/2024 (MT Newswires) -- Honeywell International's ( HON ) deal with Canadian aircraft manufacturer Bombardier is neutral-to-slightly-positive for the company, RBC Capital Markets said in a note e-mailed Tuesday. Late Monday, the industrial conglomerate agreed to provide avionics, engines and satellite communications to Bombardier jets. The companies also settled all pending litigation between them. As a result...
Intra-Cellular Therapies Files Supplemental NDA for Caplyta as Adjunctive Treatment for Major Depressive Disorder
Dec 3, 2024
10:59 AM EST, 12/03/2024 (MT Newswires) -- Intra-Cellular Therapies ( ITCI ) filed a supplemental new drug application with the US Food and Drug Administration for Caplyta as an add-on treatment for major depressive disorder. The submission is backed by two positive phase 3 studies demonstrating the drug's robust antidepressant efficacy and favorable safety and tolerability profile, the company said...
Exclusive-Biden administration will not finalize clean fuel tax credit guidance
Dec 3, 2024
(Reuters) - Biden administration officials will not finalize highly anticipated guidelines on new clean fuel production tax credits aimed at the airline and biofuel industries before they leave in January, three sources told Reuters, casting doubt on the future of a key piece of the U.S. president's climate agenda. The tax credit, the engine behind President Joe Biden's ambitious plan...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2025 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP